Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studiesResearch article Published on 2020-07-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] SARS, 신약개발, [키워드] absence anti-viral drug benefit Clinical effect Clinical outcome clinical study compassionate use conducted control arm COVID-19 Critical database double-blind effective English language faster in vitro in vivo inhibit SARS-CoV-2 medRxiv Mortality patients with COVID-19 placebo-controlled randomized controlled study randomized trial Remdesivir reported Result retrieved SARS-Co-V-2 SARS-COV-2 infection searched severe COVID-19 shown Side effect Time to recovery Treatment Trial trials while Wuhan [DOI] 10.1016/j.dsx.2020.05.018 [Article Type] Research article